Study of Sexuality in Parkinson Disease (Sex-PD)
The aim of this study is to evaluate the different aspects of sexual function among adults with Parkinson Disease to develop a treatment and address sexual problems as a routine part of diagnostic workup and therapeutic planning.
|Study Type:||Observational [Patient Registry]|
|Study Design:||Observational Model: Case Control
Time Perspective: Cross-Sectional
|Target Follow-Up Duration:||1 Day|
|Official Title:||Study of Sexuality in Parkinson Disease|
- BISF [ Time Frame: Baseline ] [ Designated as safety issue: No ]Brief Index of Sexual Functioning (BISF-M for man; BISF-W for woman)International Index of Erectile Function (IIEF) Female Sexual Function Index (FSFI)
- BDI [ Time Frame: Baseline ] [ Designated as safety issue: No ]Beck Depression Inventory (BDI) is a 21.-item self report inventory, for measuring the severity of depression in clinical and nonclinical populations.
- PDQ8 [ Time Frame: Baseline ] [ Designated as safety issue: No ]Parkinson' Disease Questionnaire-8 (PDQ- 8) is a self completion PRO designed to address aspects of functioning and well-being for those affected by Parkinson's disease.
|Study Start Date:||January 2010|
|Study Completion Date:||November 2012|
|Primary Completion Date:||November 2012 (Final data collection date for primary outcome measure)|
Patients with Parkinson Disease
Because there is limited literature on sexual function in Parkinson disease, in this study, we examined sexual functioning in a large groups of patients with idiopathic Parkinson Disease compared with healthy subjects in the Italian community. To assess sexual function in PD we used the Brief Index of Sexual Functioning [(BISF-M for man; BISF-W for woman), the International Index of Erectile Function (IIEF) and the Female Sexual Function Index (FSFI). Participants were also assessed by the Beck Depression Inventory (BDI).
This study aimed to provide a thorough epidemiological description of sexual dysfunction in Parkinson's disease. The knowledge of sexual function in PD might help to plan effective interventionist measures and ultimately to optimize patient's and the partner's quality of life.
Parkinson patients (aged 40-80) and 123 healthy controls (aged 40-80) will be recruited from four Italian Movement Disorders Clinics.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01878409
|Fondazione IRCCS Ca' Granda|
|Milano, Italy, 20122|
|Principal Investigator:||Alberto Priori, MD,PhD||Fondazione IRCCS Ca' Granda, Università di Milano|